Osimertinib resistance in non‐small cell lung cancer is mediated by sustained AKT activation through lipid raft‐dependent insulin signaling

Acquired resistance to osimertinib remains a major challenge in EGFR‐mutant non‐small cell lung cancer (NSCLC). Using an osimertinib‐resistant (AR) cell model lacking the on‐target EGFR C797S mutation, we uncover sustained AKT phosphorylation under osimertinib treatment driven by insulin receptor (INSR) signaling. Notably, INSR–AKT activation is observed exclusively in AR cells, whereas parental H1975 cells fail to activate AKT even following INSR overexpression or exogenous insulin stimulation. Cholesterol depletion abolishes the INSR–AKT response in AR cells, indicating a lipid raft‐dependent mechanism. Consistently, INSR localizes within lipid rafts in AR but not in parental H1975 cells. Proteomic profiling reveals the enrichment of lipid raft‐associated proteins in AR cells. Among them, flotillin‐1 (FLOT1) is identified as a key raft scaffold mediating INSR–AKT signaling and osimertinib resistance through functional shRNA screening. Co‐immunoprecipitation and proximity ligation assay confirm a cholesterol‐dependent interaction between FLOT1 and INSR. Functionally, FLOT1 knockdown disrupts raft‐associated INSR localization, attenuates AKT activation, and reduces the IC 50 of osimertinib in AR cells. Collectively, these findings demonstrate that lipid raft‐dependent INSR–AKT signaling contributes to osimertinib resistance in NSCLC.

Authors

Institutions

Publication Details

Journal
Molecular Oncology
Published
2026-11-16
DOI
https://doi.org/10.1002/1878-0261.70360
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Osimertinib resistance in non‐small cell lung cancer is mediated by sustained AKT activation through lipid raft‐dependent insulin signaling

Ching‐Chow Chen, Jin‐Yuan Shih, Yen‐Lin Lai
3 links
Molecular Oncology
Lung Cancer Treatments and Mutations
article

Osimertinib resistance in non‐small cell lung cancer is mediated by sustained AKT activation through lipid raft‐dependent insulin signaling

Ching‐Chow Chen, Jin‐Yuan Shih, Yen‐Lin Lai
article en

Abstract

Acquired resistance to osimertinib remains a major challenge in EGFR‐mutant non‐small cell lung cancer (NSCLC). Using an osimertinib‐resistant (AR) cell model lacking the on‐target EGFR C797S mutation, we uncover sustained AKT phosphorylation under osimertinib treatment driven by insulin receptor (INSR) signaling. Notably, INSR–AKT activation is observed exclusively in AR cells, whereas parental H1975 cells fail to activate AKT even following INSR overexpression or exogenous insulin stimulation. Cholesterol depletion abolishes the INSR–AKT response in AR cells, indicating a lipid raft‐dependent mechanism. Consistently, INSR localizes within lipid rafts in AR but not in parental H1975 cells. Proteomic profiling reveals the enrichment of lipid raft‐associated proteins in AR cells. Among them, flotillin‐1 (FLOT1) is identified as a key raft scaffold mediating INSR–AKT signaling and osimertinib resistance through functional shRNA screening. Co‐immunoprecipitation and proximity ligation assay confirm a cholesterol‐dependent interaction between FLOT1 and INSR. Functionally, FLOT1 knockdown disrupts raft‐associated INSR localization, attenuates AKT activation, and reduces the IC 50 of osimertinib in AR cells. Collectively, these findings demonstrate that lipid raft‐dependent INSR–AKT signaling contributes to osimertinib resistance in NSCLC.

Molecular Oncology
National Taiwan University (TW), National Taiwan University Hospital (TW)
Good health and well-being
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon